151 related articles for article (PubMed ID: 11029766)
1. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma.
Arihiro K; Kaneko M; Fujii S; Inai K; Yokosaki Y
Breast Cancer; 2000 Jan; 7(1):19-26. PubMed ID: 11029766
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
3. Correlation of alpha 2 beta 1 integrin expression with histological type and hormonal receptor status in breast carcinomas.
Lanzafame S; Emmanuele C; Torrisi A
Pathol Res Pract; 1996 Oct; 192(10):1031-8. PubMed ID: 8958553
[TBL] [Abstract][Full Text] [Related]
4. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
Pignatelli M; Cardillo MR; Hanby A; Stamp GW
Hum Pathol; 1992 Oct; 23(10):1159-66. PubMed ID: 1383121
[TBL] [Abstract][Full Text] [Related]
5. Integrin expression on normal and neoplastic human breast epithelium.
Damjanovich L; Fülöp B; Adány R; Nemes Z
Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
8. Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways.
Weinacker A; Ferrando R; Elliott M; Hogg J; Balmes J; Sheppard D
Am J Respir Cell Mol Biol; 1995 May; 12(5):547-56. PubMed ID: 7537970
[TBL] [Abstract][Full Text] [Related]
9. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
10. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
[TBL] [Abstract][Full Text] [Related]
11. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J
Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
14. Expression of alpha(v)beta6 integrin in oral leukoplakia.
Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
[TBL] [Abstract][Full Text] [Related]
15. Keratinocytes in human wounds express alpha v beta 6 integrin.
Haapasalmi K; Zhang K; Tonnesen M; Olerud J; Sheppard D; Salo T; Kramer R; Clark RA; Uitto VJ; Larjava H
J Invest Dermatol; 1996 Jan; 106(1):42-8. PubMed ID: 8592080
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
17. Integrin expression in primary breast cancer and its relation to axillary nodal status.
Gui GP; Wells CA; Browne PD; Yeomans P; Jordan S; Puddefoot JR; Vinson GP; Carpenter R
Surgery; 1995 Jan; 117(1):102-8. PubMed ID: 7809822
[TBL] [Abstract][Full Text] [Related]
18. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of Runx3 promoter in different breast lesions].
Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792
[TBL] [Abstract][Full Text] [Related]
20. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
